Sunshine Biopharma (SBFM US): Synthetic Expert Call Transcript (05 Oct 2026)
Preclinical Oncology Overpromise: Despite aggressive press releases regarding the K1.1 mRNA program’s in vivo mouse data, the asset remains years...
IPO Databook: Sunshine Biopharma (SBFM US) - Oct 2026
Sunshine Biopharma Inc. is a pharmaceutical company researching life-saving medicines in oncology and antivirals, marketing 60 generic...
Primer: Sunshine Biopharma (SBFM US) - Aug 2026
Sunshine Biopharma operates a hybrid business model, combining a revenue-generating generic pharmaceuticals business in Canada with a...
No more insights